Rare blood clotting syndrome linked to COVID-19 vaccines explored in study

Major new analysis from the Thrombotic Thrombocytopenia Syndrome (TTS) Consortium has provided critical insights into the rare but serious condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup